4.3 Article

Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Recovery of cognitive function after relapse in multiple sclerosis

Ralph H. B. Benedict et al.

Summary: This study found that cognitive decline in multiple sclerosis (MS) patients during relapse is followed by significant recovery post-relapse. Specifically, cognitive processing speed and ambulation show meaningful clinical improvements after relapse.

MULTIPLE SCLEROSIS JOURNAL (2021)

Article Clinical Neurology

Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses

Sarah A. Morrow et al.

Summary: This study demonstrates that incorporating the SDMT and FSS into the EDSS improves the accuracy of detecting cognitive changes during relapse activity. The modified CFSS (m-CFSS) and modified EDSS (m-EDSS) showed significantly higher scores during relapse, accounting for cognitive performance and fatigue rating.

MULTIPLE SCLEROSIS JOURNAL (2021)

Article Clinical Neurology

Siponimod and Cognition in Secondary Progressive Multiple Sclerosis EXPAND Secondary Analyses

Ralph H. B. Benedict et al.

Summary: The study shows that siponimod has a significant benefit on cognitive processing speed in patients with secondary progressive multiple sclerosis. Siponimod-treated patients were at significantly lower risk for a >= 4-point decrease in SDMT score and had a significantly higher chance for a >= 4-point increase, which is considered clinically meaningful.

NEUROLOGY (2021)

Article Clinical Neurology

Ecological impact of isolated cognitive relapses in MS

Riccardo Meli et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis

Lauren Strober et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Article Clinical Neurology

Recommendations for cognitive screening and management in multiple sclerosis care

Rosalind Kalb et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Clinical Neurology

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis

Ralph H. B. Benedict et al.

MULTIPLE SCLEROSIS JOURNAL (2017)

Review Clinical Neurology

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis

Ralph H. B. Benedict et al.

MULTIPLE SCLEROSIS JOURNAL (2017)

Article Clinical Neurology

Isolated cognitive relapses in multiple sclerosis

Matteo Pardini et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Clinical Neurology

Characterizing cognitive function during relapse in multiple sclerosis

Ralph H. B. Benedict et al.

MULTIPLE SCLEROSIS JOURNAL (2014)

Review Clinical Neurology

Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?

Ralph H. B. Benedict et al.

MULTIPLE SCLEROSIS JOURNAL (2012)

Article Clinical Neurology

Effects of acute relapses on neuropsychological status in multiple sclerosis patients

S. A. Morrow et al.

JOURNAL OF NEUROLOGY (2011)

Article Psychology, Clinical

Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline

Sarah A. Morrow et al.

CLINICAL NEUROPSYCHOLOGIST (2010)

Review Medicine, General & Internal

Diagnosis and treatment of multiple sclerosis

TJ Murray

BRITISH MEDICAL JOURNAL (2006)

Article Clinical Neurology

Reliable screening for neuropsychological impairment in multiple sclerosis

RHB Benedict et al.

MULTIPLE SCLEROSIS JOURNAL (2004)

Article Psychology, Multidisciplinary

Measuring improvement or decline on the WAIS-R in inpatient psychiatry

GL Iverson et al.

PSYCHOLOGICAL REPORTS (2001)